Victor Ling

Victor Ling (born March 16, 1943 in China ) is a Canadian biochemist who researches the mode of action of chemotherapeutic agents against cancer.

Ling came to Canada from China as a child. He graduated from the University of Toronto with a bachelor's degree in 1966 and received his PhD in biochemistry in 1969. From 1971 to 1996 he was at the Ontario Cancer Institute and from 1983 to 1996 Professor of Medical Biophysics at the University of Toronto. Since 1996 he has been a professor in the Faculty of Pathology and Biochemistry at the University of British Columbia (UBC). He is co-director of the Center for Integrated Genomics and Assistant Dean of Cancer Research at UBC Medical School and Vice President of Research for the British Columbia Cancer Agency in Vancouver.

Ling is an expert on multiple resistance of tumors to chemotherapeutic agents and discovered a protein ( P-glycoprotein ) that is responsible for this in many tumors (but also in some normal cells ), the first such multidrug resistance protein .

In 1992 he received the Gairdner Foundation International Award . He received the Cancer Research Award from the Milken Family Foundation in 1988, the Kettering Prize in 1991 , the Robert L. Noble Prize of the National Cancer Institute of Canada in 1994 , and the Dr. Josef Steiner Cancer Research Prize and in 1993 the Bruce F. Cain Memorial Award from the American Association of Cancer Research. He is a Fellow of the Royal Society of Canada . He is a member of the Order of British Columbia (2000) and an officer of the Order of Canada (2008). In 2006 he received an honorary doctorate from Trinity Western University .

Web links

• Victor Ling at the BC Cancer Agency (bccrc.ca); accessed on February 13, 2016

Individual evidence

1. ↑ Birth and career data according to American Men and Women of Science , Thomson Gale 2004
2. ↑ RL Juliano, V. Ling A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants , Biochim. Biophys. Acta , Vol. 455, 1976, pp. 152-62